These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 16037751)
1. Determinants of the effect of estrogen on the progression of subclinical atherosclerosis: Estrogen in the Prevention of Atherosclerosis Trial. Karim R; Mack WJ; Lobo RA; Hwang J; Liu CR; Liu CH; Sevanian A; Hodis HN Menopause; 2005; 12(4):366-73. PubMed ID: 16037751 [TBL] [Abstract][Full Text] [Related]
2. Estrogen in the prevention of atherosclerosis. A randomized, double-blind, placebo-controlled trial. Hodis HN; Mack WJ; Lobo RA; Shoupe D; Sevanian A; Mahrer PR; Selzer RH; Liu Cr CR; Liu Ch CH; Azen SP; Ann Intern Med; 2001 Dec; 135(11):939-53. PubMed ID: 11730394 [TBL] [Abstract][Full Text] [Related]
3. Does elevated body mass modify the influence of postmenopausal estrogen replacement on atherosclerosis progression: results from the estrogen in the prevention of atherosclerosis trial. Mack WJ; Hameed AB; Xiang M; Roy S; Slater CC; Stanczyk FZ; Lobo RA; Liu CR; Liu CH; Hodis HN Atherosclerosis; 2003 May; 168(1):91-8. PubMed ID: 12732391 [TBL] [Abstract][Full Text] [Related]
4. Summaries for patients. Postmenopausal estrogen helps prevent atherosclerosis in some women. Ann Intern Med; 2001 Dec; 135(11):S-58. PubMed ID: 11759662 [No Abstract] [Full Text] [Related]
5. Inflammatory markers and progression of subclinical atherosclerosis in healthy postmenopausal women (from the Estrogen in the Prevention of Atherosclerosis Trial). Hodis HN; St John JA; Xiang M; Cushman M; Lobo RA; Mack WJ Am J Cardiol; 2008 Apr; 101(8):1131-3. PubMed ID: 18394446 [TBL] [Abstract][Full Text] [Related]
6. A dietary and exercise intervention slows menopause-associated progression of subclinical atherosclerosis as measured by intima-media thickness of the carotid arteries. Wildman RP; Schott LL; Brockwell S; Kuller LH; Sutton-Tyrrell K J Am Coll Cardiol; 2004 Aug; 44(3):579-85. PubMed ID: 15358024 [TBL] [Abstract][Full Text] [Related]
8. Measurement of plasma ox-LDL and carotid IMT may represent useful markers for atherosclerosis and may represent potential targets for therapeutic interventions. Savoiu G; Drăgan S; Cristescu C; Serban C; Noveanus L; Ionescu D; Nicola T; Duicu O; Raducan A; Voicu M Rev Med Chir Soc Med Nat Iasi; 2009; 113(2):397-401. PubMed ID: 21491821 [TBL] [Abstract][Full Text] [Related]
9. Relationship between fasting plasma glucose, atherosclerosis risk factors and carotid intima media thickness in non-diabetic individuals. Temelkova-Kurktschiev T; Koehler C; Schaper F; Henkel E; Hahnefeld A; Fuecker K; Siegert G; Hanefeld M Diabetologia; 1998 Jun; 41(6):706-12. PubMed ID: 9662054 [TBL] [Abstract][Full Text] [Related]
10. Carotid artery intima-media thickness and lipid profile in adults with growth hormone deficiency after long-term growth hormone replacement. Soares DV; Spina LD; de Lima Oliveira Brasil RR; da Silva EM; Lobo PM; Salles E; Coeli CM; Conceição FL; Vaisman M Metabolism; 2005 Mar; 54(3):321-9. PubMed ID: 15736109 [TBL] [Abstract][Full Text] [Related]
11. Effect of oral postmenopausal hormone replacement on progression of atherosclerosis : a randomized, controlled trial. Angerer P; Störk S; Kothny W; Schmitt P; von Schacky C Arterioscler Thromb Vasc Biol; 2001 Feb; 21(2):262-8. PubMed ID: 11156863 [TBL] [Abstract][Full Text] [Related]
12. Insulin-like growth factor-1 deficiency determines increased intima-media thickness at common carotid arteries in adult patients with growth hormone deficiency. Colao A; Di Somma C; Filippella M; Rota F; Pivonello R; Orio F; Vitale G; Lombardi G Clin Endocrinol (Oxf); 2004 Sep; 61(3):360-6. PubMed ID: 15355453 [TBL] [Abstract][Full Text] [Related]
13. Influence of lifestyle modification on atherosclerotic progression determined by ultrasonographic change in the common carotid intima-media thickness. Markus RA; Mack WJ; Azen SP; Hodis HN Am J Clin Nutr; 1997 Apr; 65(4):1000-4. PubMed ID: 9094885 [TBL] [Abstract][Full Text] [Related]
14. Elevated plasma phospholipid transfer protein activity is a determinant of carotid intima-media thickness in type 2 diabetes mellitus. de Vries R; Dallinga-Thie GM; Smit AJ; Wolffenbuttel BH; van Tol A; Dullaart RP Diabetologia; 2006 Feb; 49(2):398-404. PubMed ID: 16374627 [TBL] [Abstract][Full Text] [Related]
15. Relationship between serum levels of sex hormones and progression of subclinical atherosclerosis in postmenopausal women. Karim R; Hodis HN; Stanczyk FZ; Lobo RA; Mack WJ J Clin Endocrinol Metab; 2008 Jan; 93(1):131-8. PubMed ID: 17925335 [TBL] [Abstract][Full Text] [Related]
16. Postchallenge plasma glucose excursions, carotid intima-media thickness, and risk factors for atherosclerosis in Chinese population with type 2 diabetes. Hu Y; Liu W; Huang R; Zhang X Atherosclerosis; 2010 May; 210(1):302-6. PubMed ID: 20005514 [TBL] [Abstract][Full Text] [Related]
17. Carotid atherosclerosis in men with low levels of HDL cholesterol. Wilt TJ; Rubins HB; Robins SJ; Riley WA; Collins D; Elam M; Rutan G; Anderson JW Stroke; 1997 Oct; 28(10):1919-25. PubMed ID: 9341696 [TBL] [Abstract][Full Text] [Related]
18. Pravastatin, Lipids, and Atherosclerosis in the Carotid Arteries (PLAC-II). Byington RP; Furberg CD; Crouse JR; Espeland MA; Bond MG Am J Cardiol; 1995 Sep; 76(9):54C-59C. PubMed ID: 7572688 [TBL] [Abstract][Full Text] [Related]
19. Estrogen replacement therapy and progression of intimal-medial thickness in the carotid arteries of postmenopausal women. ACAPS Investigators. Asymptomatic Carotid Atherosclerosis Progression Study. Espeland MA; Applegate W; Furberg CD; Lefkowitz D; Rice L; Hunninghake D Am J Epidemiol; 1995 Nov; 142(10):1011-9. PubMed ID: 7485045 [TBL] [Abstract][Full Text] [Related]
20. Childhood obesity-related cardiovascular risk factors and carotid intima-media thickness. Simşek E; Balta H; Balta Z; Dallar Y Turk J Pediatr; 2010; 52(6):602-11. PubMed ID: 21428192 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]